628
B. Tang et al.
LETTER
J.-P. Angew. Chem. Int. Ed. 1991, 30, 1702. (d) Boyd, S. A.;
Fung, A. K. L.; Baker, W. R.; Mantei, R. A.; Armiger, Y.-L.;
Stein, H. H.; Cohen, J.; Egan, D. A.; Barlow, J. L.;
Klinghofer, V.; Verburg, K. M.; Martin, D. L.; Young, G.
A.; Polakowski, J. S.; Hoffman, D. J.; Garren, K. W.; Perun,
T. J.; Kleinert, H. D. J. Med. Chem. 1992, 35, 1735.
(e) Jacobi, P. A.; Murphree, S.; Rupprecht, F.; Zheng, W.
J. Org. Chem. 1996, 61, 2413. (f) Steinmetz, H.; Glaser, N.;
Herdtweck, E.; Sasse, F.; Reichenbach, H.; Höfle, G. Angew.
Chem. Int. Ed. 2004, 43, 4888. (g) Lee, J. S.; Kim, D.;
Lozano, L.; Kong, S. B.; Han, H. Org. Lett. 2013, 15, 554.
(4) For selected alternative approaches to the chiral 1,3-amino
alcohol functionality, see: (a) Pilli, R. A.; Russowsky, D.;
Dias, L. C. J. Chem. Soc., Chem. Commun. 1987, 1053.
(b) Pilli, R. A.; Russowsky, D.; Dias, L. C. J. Chem. Soc.,
Perkin Trans. 1 1990, 1213. (c) Ghosh, A. K.; Bilcer, G.;
Schiltz, G. Synthesis 2001, 2203. (d) Keck, G. E.; Truong, A.
P. Org. Lett. 2002, 4, 3131. (e) Olofsson, B.; Somfai, P.
J. Org. Chem. 2002, 67, 8574. (f) Benedetti, F.; Berti, F.;
Norbedo, S. J. Org. Chem. 2002, 67, 8635. (g) Wabnitz, T.
C.; Spencer, J. B. Org. Lett. 2003, 5, 2141. (h) Kochi, T.;
Tang, T.; Ellman, J. J. Am. Chem. Soc. 2003, 125, 11276.
(i) Kennedy, A.; Nelson, A.; Perry, A. Synlett 2004, 967.
(j) Adamo, I.; Benedetti, F.; Berti, F.; Campaner, P. Org.
Lett. 2006, 8, 51. (k) Menche, D.; Arikan, F.; Li, J.; Rudolph,
S. Org. Lett. 2007, 9, 267. (l) Broustal, G.; Ariza, X.;
Campagne, J.-M.; Garcia, J.; Georges, Y.; Marinetti, A.;
Robiette, R. Eur. J. Org. Chem. 2007, 4293. (m) Ghorai, M.;
Das, K.; Kumar, A. Tetrahedron Lett. 2007, 48, 4373.
(n) Koehler, F.; Gais, H. J.; Raabe, G. Org. Lett. 2007, 9,
1231. (o) Zalatan, D. N.; Du Bois, J. J. Am. Chem. Soc. 2008,
130, 9220. (p) Weiner, B.; Baeza, A.; Jerphagnon, T.;
Feringa, B. L. J. Am. Chem. Soc. 2009, 131, 9473. (q) Rice,
G. T.; White, M. C. J. Am. Chem. Soc. 2009, 131, 11707.
(r) Paradine, S. M.; White, M. C. J. Am. Chem. Soc. 2012,
134, 2036.
Ph
Ph
6
O
NTs
O
NTs
2
4
15
11
dr 7.4:1.0:2.5:3.3a (57%)b
dr 3.9:1.0:2.7:1.5a (67%)b
(2,4-syn/anti = 2.2:1)
(2,4-syn/anti = 1.2:1)
Ph
Ph
O
NTs
OMe
O
NTs
12
16
dr 10.1:1.0:2.7:2.8a (62%)b
dr 9.8:2.1:3.9:1.0a (63%)b
(2,4-syn/anti = 2.1:1)
(2,4-syn/anti = 2.4:1)
Ph
Ph
O
NTs
O
NTs
MeO
17
13
dr 5.2:1.0:1.1:1.1a (51%)b
dr 8.0:1.7:4.5:1.0a (69%)b
(2,4-syn/anti = 2.8:1)
(2,4-syn/anti = 1.7:1)
Ph
Ph
O
NTs
O
NTs
18
14
dr 5.2:1.0:1.5:2.2a (55%)b
dr 1.9:1.5:2.7:1.0a (53%)b
(2,4-syn/anti = 1.7:1)
(2,4-syn/anti = 0.9:1)
(5) (a) Wang, L.; Li, P.; Menche, D. Angew. Chem. Int. Ed.
2010, 49, 9270. (b) Morgen, M.; Bretzke, S.; Li, P.; Menche,
D. Org. Lett. 2010, 12, 4494. (c) Wang, L.; Menche, D.
Angew. Chem. Int. Ed. 2012, 51, 9425. (d) Wang, L.;
Menche, D. J. Org. Chem. 2012, 77, 10811.
a dr for (6-epi)-, (4-epi)- and (4-epi, 6-epi)-isomer given
b combined yield
Figure 1
(6) For a domino reaction involving a hemiaminalization, see:
Urushima, T.; Sakamoto, D.; Ishikawa, H.; Hayashi, Y. Org.
Lett. 2010, 12, 4588.
Acknowledgment
(7) van Benthem, R. A. T. M.; Hiemstra, H.; Michels, J. J.;
Speckamp, W. N. J. Chem. Soc., Chem. Commun. 1994, 357.
(8) All required homoallylic substrates were readily prepared by
allylation of the respective aldehyde and subsequent cross-
metathesis, as previously described; see ref. 4.
Generous financial support by the Deutsche Forschungsgemein-
schaft (SFB 623 ‘Molekulare Katalysatoren: Struktur und Funk-
tionsdesign’) and the Chinese Scholarship Council (CSC,
scholarship to B.T.) is gratefully acknowledged. Furthermore, we
thank Andreas J. Schneider for HPLC support.
(9) N-Arenesulfonyl aldimines were readily prepared from
aliphatic and aromatic aldehydes in a two-step
transformation. See: Chemla, F.; Hebbe, V.; Normant, J.-F.
Synthesis 2000, 75.
Supporting Information for this article is available online at
m
iotSrat
ungIifoop
r
t
(10) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921.
(11) In all cases, stereochemical assignment was based on NMR
methods. Scheme 4 shows an example.
References and Notes
(1) Present address: University of Basel, Switzerland.
(2) (a) Pinder, A. R. Nat. Prod. Rep. 1992, 9, 491. (b) Plunkett,
A. O. Nat. Prod. Rep. 1994, 11, 581. (c) Cossy, J.; Willis, C.;
Bellosta, V.; BouzBouz, S. J. Org. Chem. 2002, 67, 1982.
(d) Fustero, S.; Jimenéz, D.; Moscardó, J.; Catalán, S.; Pozo,
C. Org. Lett. 2007, 9, 5283.
Ph
Ph
3
Ts
Ha
O
N
O
NTs
H
2
=
1
Ar
H
Hb
H
H
(3) For examples of bioactive 1,3-amino alcohols, see:
(a) Wang, Y.-F.; Izawa, T.; Kobayashi, S.; Ohno, M. J. Am.
Chem. Soc. 1982, 104, 6465. (b) Colau, B.; Hootelk, C. Can.
J. Chem. 1983, 61, 470. (c) Benz, G.; Henning, R.; Stasch,
11a
: NOE
correlation
Scheme 4
Synlett 2013, 24, 625–629
© Georg Thieme Verlag Stuttgart · New York